Tarsier Pharma's Positive End-of-Phase 2 Meeting with the U.S. FDA Sets Stage for TRS01 Phase III Program in Uveitis
December 17, 2020 08:32 ET
|
Tarsius Pharma
TEL-AVIV, Israel, Dec. 17, 2020 (GLOBE NEWSWIRE) -- Tarsier Pharma (doing business as Tarsius Pharma Ltd.), a late clinical stage pharmaceutical company focused on the development and...
Tarsius Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference
November 23, 2020 16:01 ET
|
Tarsius Pharma
TEL-AVIV, Israel, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Tarsius Pharma, a clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat patients...